Twitter Updates

    follow me on Twitter

    Friday, February 26, 2010

    FDA Approves New Treatment for Shingles-Related Pain

    The FDA has approved Qutenza, a patch containing 8% capsaicin, to treat postherpetic neuralgia. Qutenza must be applied to the skin by a healthcare professional. It can be used for 60 minutes, as often as once every 3 months, according to the manufacturer.

    Before placing a patch, providers should treat the affected area with a topical anesthetic. In addition, they should monitor patients for at least 1 hour after patch application because of the risk for increased blood pressure. Other side effects may include pain, swelling, itching, redness, and bumps at the application site.Capsaicin, a compound in chili peppers, is available in over-the-counter products in lower concentrations, but this is the first prescription-level formulation approved by the FDA.

    Please remember, as with all our articles we provide information, not medical advice.
    For any treatment of your own medical condition you must visit your local doctor, with or without our article[s]. These articles are not to be taken as individual medical advice.

    Deepen your understanding of "medical malpractice"...

    For more health info and links visit the author's web site

    No comments:

    Post a Comment